Gordon et al. demonstrated that PD-1 expression in TAMs increased over time in mouse models of cancer and with increasing disease stage in human cancers and that the PD-1/PD-L1 axis blockade increased the antitumor efficacy of TAMs (19). This evidence concerns the gene CD274 and cancer.